Endocannabinoid System Research: Cannabis for Autism Spectrum Disorder
Cannabis derivatives autism spectrum disorder research shows promising early signals for improving core symptoms and behavioral challenges. Current clinical trials reveal potential benefits but remain limited in size and scope. More research is needed to…
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Adolescents with internalising symptoms are at increased risk for cannabis use. This study highlights the internalising pathway cannabis use adolescents face. Anxiety and depression symptoms predict cannabis initiation.
Adolescent Cannabis Use: Mental Health Risks Examined
Adolescent cannabis use and mental health clinical evidence show a significant association with increased risk of psychiatric disorders. This includes psychotic, bipolar, depressive, and anxiety disorders diagnosed in adolescence and young adulthood.…
Endocannabinoid System Research: Trauma, Sleep & Cannabis Use
Pre-trauma insomnia substance use risk is a significant factor in predicting alcohol and cannabis use following trauma. This research highlights the importance of screening for sleep disturbances in trauma survivors. Addressing pre-trauma insomnia…
Endocannabinoid System & Adolescent Health: 15-Year REAL 2.0 Study
This 15-year REAL 2.0 study highlights endocannabinoid system adolescent health research focusing on eating disorders and mental health outcomes. It tracks youth into adulthood to understand psychosocial risk factors. The findings emphasize early…
Clinical Evidence on Cannabinoids in PTSD and Substance Use
Cannabinoids and PTSD clinical evidence indicate that trauma-focused treatments benefit patients with co-occurring substance use disorders. Cannabis use does not diminish the effectiveness of evidence-based PTSD care. Clinicians should consider this…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
Research on Cannabis Use and Behavioral Outcomes in Children with ASD
Peripregnancy cannabis exposure behavioral outcomes show varied effects on children with and without ASD symptoms. This research highlights differences in behavioral and developmental associations. Understanding these outcomes is crucial for counseling…
Endocannabinoid System & GLP-1 Mental Health Evidence
GLP-1 receptor agonists mental health evidence suggests these drugs may influence psychiatric disorder risks. Genetic studies indicate potential benefits for schizophrenia. Patients should discuss mental health implications with clinicians.
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
This study evaluates a rebuttal-based social norms-tailored cannabis intervention designed to improve prevention messaging for at-risk adolescents. Personalized approaches challenge negative reactions to standard cannabis messages. Findings support…